Security key
05156V102
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 54,674,386
- Total 13F value
- $273,920,542
- Share change
- +1,749,451
- Put/Call ratio
- 141%
- SEC-reported price per share
- $5.01
- Number of holders
- 173
- Value change
- +$3,860,760
- Number of buys
- 69
- Number of sells
- 97
- Shares outstanding
- 130,441,060
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
173
Top holders
10
AUPH full security history
Ownership snapshot
Full 13F holder table
Aurinia Pharmaceuticals Inc. SEC filings
Aurinia Pharmaceuticals Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 7.3%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 7.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
7.3%
BlackRock Finance, Inc.
6.8%
NEA Management Company, LLC
3%
STATE STREET CORP
2.1%
Nuveen Asset Management, LLC
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
7.3%
|
$85,728,640
9,536,000 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
6.8%
|
$80,200,231
8,921,049 shares
|
— | 31 Dec 2023 |
| NEA Management Company, LLC |
13F
Company
|
3%
|
$35,688,808
3,969,834 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
2.1%
|
$24,312,394
2,704,382 shares
|
— | 31 Dec 2023 |
| Nuveen Asset Management, LLC |
13F
Company
|
1.8%
|
$21,145,604
2,352,125 shares
|
— | 31 Dec 2023 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
1.6%
|
$18,415,619
2,048,456 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
173
Shares
54,674,386
Rows available
173
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
173
Q1 2024 holders
173
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|